Table 3.
Discontinuation and side effects by metaboliser status.
| Discontinutation No. (%) | Any side effect No. (%) | |||
|---|---|---|---|---|
| No | Yes | Yes | No | |
| Sertraline | ||||
| Poor | 63 (66) | 32 (34) | 98 (74) | 34 (26) |
| Intermediate | 610 (54) | 519 (46) | 1121 (73) | 405 (27) |
| Normal | 917 (54) | 775 (46) | 1683 (70) | 716 (30) |
| Rapid | 598 (56) | 466 (44) | 1069 (69) | 480 (31) |
| Ultrarapid | 100 (52) | 93 (48) | 190 (70) | 83 (30) |
| Citalopram | ||||
| Poor | 23 (57) | 17 (43) | 39 (71) | 16 (30) |
| Intermediate | 256 (53) | 224 (47) | 478 (67) | 232 (33) |
| Normal | 360 (55) | 290 (45) | 656 (65) | 356 (35) |
| Rapid | 285 (59) | 199 (41) | 501 (67) | 246 (33) |
| Ultrarapid | 44 (56) | 34 (44) | 78 (65) | 41 (34) |
| Escitalopram | ||||
| Poor | 33 (55) | 27 (45) | 60 (75) | 20 (25) |
| Intermediate | 522 (62) | 322 (38) | 846 (73) | 319 (27) |
| Normal | 791 (62) | 493 (38) | 1300 (71) | 534 (29) |
| Rapid | 562 (66) | 291 (34) | 857 (69) | 385 (31) |
| Ultrarapid | 82 (60) | 55 (40) | 142 (71) | 58 (29) |